Search research articles
Contact Us
Filters
Showing results (11-20 of 33) with videos related to
Page
of 4
Sort By:
Cancer Chemotherapy and Pharmacology
|
January 1, 1990
Phase I study of mitozolomide on a once daily for 5 days schedule
J H Schornagel, G Simonetti, R Dubbelman, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1992
Clinical pharmacokinetics of mitoxantrone after intraperitoneal administration
J D Nagel, F J Varossieau, R Dubbelman, et al.
Cancer Chemotherapy and Pharmacology
|
July 27, 2000
Feasibility and pharmacokinetics of intraperitoneal suramin in advanced malignancy
A M Westermann, R Dubbelman, J P Baars, et al.
Thorax
|
May 1, 1993
Central venous catheter associated thrombosis of major veins: thrombolytic treatment with recombinant tissue plasminogen activator
S Rodenhuis, L G van't Hek, L T Vlasveld, et al.
British Journal of Cancer
|
February 1, 1991
Formation of interaction products of carboplatin with DNA in vitro and in cancer patients
P M Terheggen, A C Begg, J Y Emondt, et al.
Transfusion
|
July 22, 2004
Positively charged porphyrins: a new series of photosensitizers for sterilization of RBCs
Laurence L Trannoy, Johan W M Lagerberg, Tom M A R Dubbelman, et al.
Cancer Treatment Reviews
|
September 1, 1985
Phase I study and pharmacokinetics of intraperitoneal carboplatin
J G McVie, W ten Bokkel Huinink, R Dubbelman, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1994
Bioavailability of oral etoposide in gastric cancer
B G Taal, J H Beijnen, F G Teller, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 1, 1994
Phase I/II study of intraperitoneal mitoxantrone in refractory ovarian cancer
A M Oza, W ten Bokkel Huinink, R Dubbelman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 1, 1994
Etoposide, leucovorin, 5-fluorouracil (ELF) combination chemotherapy for advanced gastric cancer: experience with two treatment schedules incorporating intravenous or oral etoposide
B G Taal, F G Teller, W W ten Bokkel Huinink, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 33) with videos related to
Sort By:
Page
of 4
Cancer Chemotherapy and Pharmacology
|
January 1, 1990
Phase I study of mitozolomide on a once daily for 5 days schedule
J H Schornagel, G Simonetti, R Dubbelman, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1992
Clinical pharmacokinetics of mitoxantrone after intraperitoneal administration
J D Nagel, F J Varossieau, R Dubbelman, et al.
Cancer Chemotherapy and Pharmacology
|
July 27, 2000
Feasibility and pharmacokinetics of intraperitoneal suramin in advanced malignancy
A M Westermann, R Dubbelman, J P Baars, et al.
Thorax
|
May 1, 1993
Central venous catheter associated thrombosis of major veins: thrombolytic treatment with recombinant tissue plasminogen activator
S Rodenhuis, L G van't Hek, L T Vlasveld, et al.
British Journal of Cancer
|
February 1, 1991
Formation of interaction products of carboplatin with DNA in vitro and in cancer patients
P M Terheggen, A C Begg, J Y Emondt, et al.
Transfusion
|
July 22, 2004
Positively charged porphyrins: a new series of photosensitizers for sterilization of RBCs
Laurence L Trannoy, Johan W M Lagerberg, Tom M A R Dubbelman, et al.
Cancer Treatment Reviews
|
September 1, 1985
Phase I study and pharmacokinetics of intraperitoneal carboplatin
J G McVie, W ten Bokkel Huinink, R Dubbelman, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1994
Bioavailability of oral etoposide in gastric cancer
B G Taal, J H Beijnen, F G Teller, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 1, 1994
Phase I/II study of intraperitoneal mitoxantrone in refractory ovarian cancer
A M Oza, W ten Bokkel Huinink, R Dubbelman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 1, 1994
Etoposide, leucovorin, 5-fluorouracil (ELF) combination chemotherapy for advanced gastric cancer: experience with two treatment schedules incorporating intravenous or oral etoposide
B G Taal, F G Teller, W W ten Bokkel Huinink, et al.
Page
of 4